These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 29510967)

  • 21. Three years of growth hormone treatment in young adults with Prader-Willi Syndrome previously treated with growth hormone in childhood: Effects on glucose homeostasis and metabolic syndrome.
    Damen L; Grootjen LN; Donze SH; Juriaans AF; de Graaff LCG; van der Velden JAEM; Hokken-Koelega ACS
    Clin Endocrinol (Oxf); 2020 Oct; 93(4):439-448. PubMed ID: 32609902
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Growth hormone treatment for two years is safe and effective in adults with Prader-Willi syndrome.
    Sode-Carlsen R; Farholt S; Rabben KF; Bollerslev J; Schreiner T; Jurik AG; Frystyk J; Christiansen JS; Höybye C
    Growth Horm IGF Res; 2011 Aug; 21(4):185-90. PubMed ID: 21664161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sustained benefit after 2 years of growth hormone on body composition, fat utilization, physical strength and agility, and growth in Prader-Willi syndrome.
    Myers SE; Carrel AL; Whitman BY; Allen DB
    J Pediatr; 2000 Jul; 137(1):42-9. PubMed ID: 10891820
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prader-Willi syndrome and growth hormone deficiency.
    Aycan Z; Baş VN
    J Clin Res Pediatr Endocrinol; 2014; 6(2):62-7. PubMed ID: 24932597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome.
    Höybye C; Thorén M; Böhm B
    J Intellect Disabil Res; 2005 Apr; 49(Pt 4):245-52. PubMed ID: 15816811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The use of growth hormone therapy in adults with Prader-Willi syndrome: A systematic review.
    Frixou M; Vlek D; Lucas-Herald AK; Keir L; Kyriakou A; Shaikh MG
    Clin Endocrinol (Oxf); 2021 Apr; 94(4):645-655. PubMed ID: 33296095
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome.
    de Lind van Wijngaarden RF; Siemensma EP; Festen DA; Otten BJ; van Mil EG; Rotteveel J; Odink RJ; Bindels-de Heus GC; van Leeuwen M; Haring DA; Bocca G; Houdijk EC; Hoorweg-Nijman JJ; Vreuls RC; Jira PE; van Trotsenburg AS; Bakker B; Schroor EJ; Pilon JW; Wit JM; Drop SL; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2009 Nov; 94(11):4205-15. PubMed ID: 19837938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Growth Hormone Treatment in Children With Prader-Willi Syndrome: Three Years of Longitudinal Data in Prepubertal Children and Adult Height Data From the KIGS Database.
    Bakker NE; Lindberg A; Heissler J; Wollmann HA; Camacho-Hübner C; Hokken-Koelega AC;
    J Clin Endocrinol Metab; 2017 May; 102(5):1702-1711. PubMed ID: 28323917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth hormone, gender and face shape in Prader-Willi syndrome.
    de Souza MA; McAllister C; Suttie M; Perrotta C; Mattina T; Faravelli F; Forzano F; Holland A; Hammond P
    Am J Med Genet A; 2013 Oct; 161A(10):2453-63. PubMed ID: 23918156
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Growth hormone treatment for adults with Prader-Willi syndrome: another point of view.
    Hirsch HJ; Gross-Tsur V
    Orphanet J Rare Dis; 2021 Aug; 16(1):337. PubMed ID: 34344408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exacerbation of BMI after cessation of growth hormone therapy in patients with Prader-Willi syndrome.
    Oto Y; Tanaka Y; Abe Y; Obata K; Tsuchiya T; Yoshino A; Murakami N; Nagai T
    Am J Med Genet A; 2014 Mar; 164A(3):671-5. PubMed ID: 24443368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prader-Willi syndrome and growth hormone treatment].
    Castinetti F; Reynaud R; Brue T
    Ann Endocrinol (Paris); 2008 Sep; 69 Suppl 1():S6-S10. PubMed ID: 18954862
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Visceral adipose tissue increases shortly after the cessation of GH therapy in adults with Prader-Willi syndrome.
    Koizumi M; Ida S; Shoji Y; Nishimoto Y; Etani Y; Kawai M
    Endocr J; 2018 Nov; 65(11):1127-1137. PubMed ID: 30185718
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Growth hormone usage in Prader-Willi syndrome].
    Damiani D
    Arq Bras Endocrinol Metabol; 2008 Jul; 52(5):833-8. PubMed ID: 18797590
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of genetic subtypes of Prader-Willi syndrome with growth hormone therapy on intelligence and body mass index.
    Butler MG; Matthews NA; Patel N; Surampalli A; Gold JA; Khare M; Thompson T; Cassidy SB; Kimonis VE
    Am J Med Genet A; 2019 Sep; 179(9):1826-1835. PubMed ID: 31313492
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial.
    Mogul HR; Lee PD; Whitman BY; Zipf WB; Frey M; Myers S; Cahan M; Pinyerd B; Southren AL
    J Clin Endocrinol Metab; 2008 Apr; 93(4):1238-45. PubMed ID: 18211968
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Growth hormone secretion decreases with age in paediatric Prader-Willi syndrome.
    Cohen M; Harrington J; Narang I; Hamilton J
    Clin Endocrinol (Oxf); 2015 Aug; 83(2):212-5. PubMed ID: 25495188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of IGF1/IGFBP3 Molar Ratio as an Effective Tool for Assessing the Safety of Growth Hormone Therapy in Small-for-gestational-age, Growth Hormone-Deficient and Prader-Willi Children.
    Gaddas M; Périn L; Le Bouc Y
    J Clin Res Pediatr Endocrinol; 2019 Sep; 11(3):253-261. PubMed ID: 30759961
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment.
    Festen DA; de Weerd AW; van den Bossche RA; Joosten K; Hoeve H; Hokken-Koelega AC
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4911-5. PubMed ID: 17003096
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Growth hormone treatment improves body composition in adults with Prader-Willi syndrome.
    Höybye C; Hilding A; Jacobsson H; Thorén M
    Clin Endocrinol (Oxf); 2003 May; 58(5):653-61. PubMed ID: 12699450
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.